sulfasalazine has been researched along with Facial Dermatoses in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Facial Dermatoses: Skin diseases involving the FACE.
Excerpt | Relevance | Reference |
---|---|---|
"We describe a patient with drug-induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) infection induced by sulfasalazine." | 3.73 | Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation. ( Hamaguchi, Y; Hasegawa, M; Komura, K; Nagai, M; Sato, S; Takehara, K; Yachie, A; Yukami, T, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komura, K | 1 |
Hasegawa, M | 1 |
Hamaguchi, Y | 1 |
Yukami, T | 1 |
Nagai, M | 1 |
Yachie, A | 1 |
Sato, S | 1 |
Takehara, K | 1 |
Delaporte, E | 1 |
Catteau, B | 1 |
Sabbagh, N | 1 |
Gosselin, P | 1 |
Breuillard, F | 1 |
Doutre, MS | 1 |
Broly, F | 1 |
Piette, F | 1 |
Bergoend, H | 1 |
2 other studies available for sulfasalazine and Facial Dermatoses
Article | Year |
---|---|
Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation.
Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Drug Hypersensitivity; Exanthema Subitum; Facial | 2005 |
[Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
Topics: Acetylation; Acetyltransferases; Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Facial De | 1997 |